US Patent Issued to National Chung Hsing University on Oct. 27 for "Method for treating cancer using human mitochondrial malic enzyme 2 inhibitor" (Taiwanese Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,415, issued on Oct. 27, was assigned to National Chung Hsing University (Taichung City, Taiwan).

"Method for treating cancer using human mitochondrial malic enzyme 2 inhibitor" was invented by Hui-Chih Hung (Taichung City, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for treating cancer using a human mitochondrial malic enzyme 2 inhibitor includes administering an effective amount of 4,4'-methylene-bis(3-hydroxy-2-naphthoic acid), of 5,5'-methylenedisalicylic acid, or of a salt of either of the aforesaid compounds to a cancer patient to inhibit the expression of human mitochondrial malic enzyme 2 in cancer cells and hence the energ...